EMCURE PHARMACEUTICALS LTD. share price has zoomed 8% and is presently trading at Rs 1,408.0.
Meanwhile, the BSE HEALTHCARE index is at 43,178.6 (down 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (up 2.3%) and CAPLIN POINT (up 2.3%).
POLY MEDICURE (down 7.5%) and FORTIS HEALTHCARE (down 2.4%) are among the top losers today.
Over the last one year, EMCURE PHARMACEUTICALS LTD. has moved up from Rs 0.0 to Rs 1,408.0, registering a gain of Rs 1,408.0 .
On the other hand, the BSE HEALTHCARE index has moved up from 29,918.9 to 43,178.6, registering a gain of 44.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.1%), SUVEN PHARMACEUTICALS (up 110.1%) and Glenmark Pharma (up 93.4%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,955.6 (down 0.2%).
The top losers among the BSE Sensex today are Ultratech Cement (down 2.3%) and MUNDRA PORT & SEZ (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,201.3 (down 0.1%). Ultratech Cement and Adani Enterprises are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,023.2 to 79,955.6, registering a gain of 13,932.3 points (up 21.1%).
EMCURE PHARMACEUTICALS LTD. net profit fell {profitpercent} YoY to Rs 2,015 million for the quarter ended September 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 20,020 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2024, EMCURE PHARMACEUTICALS LTD. reported 6.1% decrease in net profit to Rs 5,276 million compared to net profit of Rs 5,618 million during FY23. Revenue of the company grew 11.2% to Rs 66,583 million during FY24.
Equitymaster requests your view! Post a comment on "EMCURE PHARMACEUTICALS LTD. Gains 8%; BSE HEALTHCARE Index Down 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!